|
|
| H-05 / Protheragen (0 Trials) |
|
| H-ferritin–nanocaged doxorubicin / Chinese Academy of Sciences, U Tokyo (0 Trials) |
|
| H.P. Acthar Gel (repository corticotropin injection) / Mallinckrodt (29 Trials) |
|
| H1299 cell lysate with iscomatrix adjuvant vaccine / National Cancer Institute (0 Trials) |
|
| H1N1 influenza vaccine / iBio (0 Trials) |
|
| H2Stem / Promethera Biosciences (0 Trials) |
|
| H3.3K27M TCR T cell therapy / Tmunity Therap, University of California (0 Trials) |
|
| H3B-6527 / Eisai (1 Trials) |
|
| H3B-6545 / Eisai (3 Trials) |
|
| H3B-8800 / Eisai (1 Trials) |
|
| H4 / Luhe Hospital, Chinese Academy of Sciences (0 Trials) |
|
| H4 antagonist / Sosei (0 Trials) |
|
| H4H1327P / Regeneron (0 Trials) |
|
| h5A10 / Diaprost (0 Trials) |
|
| H5N1 VLP vaccine (MT-8972) / Mitsubishi Tanabe (0 Trials) |
|
| H5NI Influenza Vaccine / iBio (0 Trials) |
|
| H7N9 Anhui 2013/AA ca / National Institute of Allergy and Infectious Diseases (0 Trials) |
|
| H7N9 vaccine (MT-7529) / Mitsubishi Tanabe (0 Trials) |
|
| HA-1 T TCR T Cell Immunotherapy / Fred Hutchinson Cancer Research Center, ElevateBio (1 Trials) |
|
| HA-irinotecan / ProBility Media Corp (3 Trials) |
|
| HA121-28 / CSPC Pharma (4 Trials) |
|
| Habeo Cell Therapy (ECCS-50) / Plus Therap (0 Trials) |
|
| Haduvio (nalbuphine ER) / Trevi Therap (3 Trials) |
|
| HAE 1 (PRO 98498) / Roche (0 Trials) |
|
| Haegarda (C1 esterase inhibitor subcutaneous [human]) / CSL Behring (0 Trials) |
|
| Haemate-P (human plasma derived von Willebrand factor/FVIII complex) / CSL Behring (1 Trials) |
|
| Haemoctin (human plasma derived coagulation factor VIII) / ADMA Biologics (0 Trials) |
|
| Haemonine (human plasma derived coagulation factor IX) / ADMA Biologics (0 Trials) |
|
| Hakin-1 / Angélica Figueroa of University of A Coruña (0 Trials) |
|
| HAL-MPE1 / HAL Allergy (0 Trials) |
|
| Halaven (eribulin mesylate) / Eisai (73 Trials) |
|
| halcinonide / Generic mfg. (1 Trials) |
|
| Halfan (halofantrine) / GSK (0 Trials) |
|
| Halimatoz (adalimumab biosimilar) / Novartis (8 Trials) |
|
| Haloart (halopredone) / LTT Bio-Pharma (0 Trials) |
|
| haloperidol / Generic mfg. (39 Trials) |
|
| haloperidol (CLR3001) / Clera (0 Trials) |
|
| haloperidol/trihexyphenidyl / Generic mfg. (0 Trials) |
|
| Halovirin nCov / Halo-Bio (0 Trials) |
|
| Halpryza (rituximab biosimilar) / Innovent Biologics, Eli Lilly (0 Trials) |
|
| Hamsa 1 (TL 118) / Tiltan Pharma (3 Trials) |
|
| Hamsa-1 (TL-118) / Tiltan Pharma (3 Trials) |
|
| Hamsyl (peg-aspargase biosimilar) / Emcure (0 Trials) |
|
| Hanferon Oral (interferon alpha-2b oral) / Daewoong Pharma (0 Trials) |
|
| Hanferon SC (interferon alpha-2b) / Daewoong Pharma (0 Trials) |
|
| Hanlikon (rituximab biosimilar) / Fosun Pharma (3 Trials) |
|
| HANP (carperitide) / Zeria Pharma, Daiichi Sankyo (0 Trials) |
|
| Hansoh Xinfu (flumatinib) / Jiangsu Hengrui Medicine, Jiangsu Hansoh Pharma (9 Trials) |
|
| HAPC1573 / Bayer, Shanghai RAAS (0 Trials) |
|
| haploid allogeneic NK cell therapy / iCELL Biotechnology (1 Trials) |
|
| Haruropi tape (ropinirole transdermal) / Hisamitsu, Kyowa Kirin (0 Trials) |
|
| HB-001 / Zhejiang Huahai Pharma (0 Trials) |
|
| HB-002 / Zhejiang Huahai Pharma (1 Trials) |
|
| HB-002 M / Zhejiang Huahai Pharma (0 Trials) |
|
| HB-101 / Hookipa Pharma (1 Trials) |
|
| HB-110E / Genexine (0 Trials) |
|
| HB-201 / Hookipa Pharma (2 Trials) |
|
| HB-202 / Hookipa Pharma (1 Trials) |
|
| HB-300 / Hookipa Pharma (0 Trials) |
|
| HB-adMSC / Hope Biosciences (7 Trials) |
|
| HB-AS 02 / GSK (1 Trials) |
|
| HB0017 / Zhejiang Huahai Pharma (0 Trials) |
|
| HB0025 / Zhejiang Huahai Pharma (1 Trials) |
|
| HB0030 / Zhejiang Huahai Pharma (0 Trials) |
|
| HBI-2376 / HUYA Bioscience (0 Trials) |
|
| hBM-MSC / Translational Research Center for Medical Innovation (0 Trials) |
|
| HBM1007 / Harbour BioMed (0 Trials) |
|
| HBM1020 / Harbour BioMed (0 Trials) |
|
| HBM1022 / Harbour BioMed (0 Trials) |
|
| HBM4003 / Harbour BioMed (3 Trials) |
|
| HBM7008 / Harbour BioMed (0 Trials) |
|
| HBM7015 / Harbour BioMed (0 Trials) |
|
| HBM7020 / Harbour BioMed (0 Trials) |
|
| HBM9001 / Sichuan Kelun Pharma, Harbour BioMed (0 Trials) |
|
| HBM9022 / Utrecht University, Erasmus MC, Harbour BioMed, AbbVie (0 Trials) |
|
| HBM9167 / Harbour BioMed (2 Trials) |
|
| HBP-bound-doxorubicin (12B80) / Atlanthera (0 Trials) |
|
| HBS-102 / Paragon Biosci (0 Trials) |
|
| HBV surface antigen secretion inhibitors / Arbutus (0 Trials) |
|
| HBV therapeutic vaccine / IMV Inc (0 Trials) |
|
| HBV vaccine / ProMed BioSci (0 Trials) |
|
| HBV viral vector and adjuvanted proteins vaccine (GSK3528869A) / GSK (1 Trials) |
|
| HBVaxPro (hepatitis-B vaccine (rDNA)) / Merck (MSD), Sanofi (5 Trials) |
|
| HBW-3-10 / Hyperway Pharma (0 Trials) |
|
| HBW-3-20 / Hyperway Pharma (0 Trials) |
|
| HBW-3090 / Hyperway Pharma (0 Trials) |
|
| HC-5404-FU / HiberCell (1 Trials) |
|
| HC-X014 / Hinova Pharma (0 Trials) |
|
| HC-X029 / Hinova Pharma (0 Trials) |
|
| HCB1019 / OcuNexus (0 Trials) |
|
| HCI-1401 / HLB Bio Group (0 Trials) |
|
| HCP1803 / Hanmi (2 Trials) |
|
| HCP1904 / Hanmi (2 Trials) |
|
| HCR040 / Noray (2 Trials) |
|
| hCT-MSC / Duke University (1 Trials) |
|
| HCV E1E2/MF59C / Novartis (0 Trials) |
|
| HCV vaccine / VBI Vaccines (0 Trials) |
|
| HCVax (lentiviral based HCV immunotherapy) / GeneCure Biotechnologies (1 Trials) |
|
| HCW9218 / HCW Biologics (0 Trials) |
|
| HD-003 / Hyundai Pharm (0 Trials) |
|
| HD-6277 / Hyundai Pharm (0 Trials) |
|
| HD-7671 / Hyundai Pharm (0 Trials) |
|
| HD204 (bevacizumab biosimilar) / Hanwha Solutions, Prestige BioPharma, Huons (1 Trials) |
|
| HD205 / Hanwha Chem (0 Trials) |
|
| HDDO-1756 / Hyundai Pharm (0 Trials) |
|
| HDIT101 / Heidelberg ImmunoTherap (2 Trials) |
|
| HDL receptor enhancer / Abionyx Pharma (0 Trials) |
|
| HDM-SPIRE / Circassia (0 Trials) |
|
| HDP-101 / Heidelberg Pharma (1 Trials) |
|
| HDT-301 / HDT Bio Corp, Emcure (0 Trials) |
|
| HDV insulin lispro (HDV-L) / Diasome (0 Trials) |
|
| HDV-interferon (interferon alpha controlled-release) / Hepasome Pharma (1 Trials) |
|
| HE-33 / Immune Modulation (0 Trials) |
|
| HE3177 / Harbor Biosci (0 Trials) |
|
| HE3413 / Harbor Biosciences (0 Trials) |
|
| head and neck cancer vaccine / Vyriad (0 Trials) |
|
| Heartcel (iMP cell therapy) / Celixir (1 Trials) |
|
| Heberitro (epoetin alfa biosimilar) / Heber Biotec, Center for Genetic Engineering and Biotechnology (0 Trials) |
|
| HeberNasvac (ABX203) / Center for Genetic Engineering and Biotechnology, Abivax (0 Trials) |
|
| Hebervital (filgrastim biosimilar) / Heber Biotec, Center for Genetic Engineering and Biotechnology (0 Trials) |
|
| HEC110114 / HEC Pharm (0 Trials) |
|
| HEC116094 / HEC Pharm (1 Trials) |
|
| HEC121120 / HEC Pharm (1 Trials) |
|
| HEC122505MsOH / HEC Pharm (1 Trials) |
|
| HEC53856 / HEC Pharm (2 Trials) |
|
| HEC68498 / HEC Pharm (1 Trials) |
|
| HEC74647PA / HEC Pharm (0 Trials) |
|
| HEC80797 / HEC Pharm (0 Trials) |
|
| HEC83518 / HEC Pharm (2 Trials) |
|
| HEC89736 / HEC Pharm (1 Trials) |
|
| HEC96719 / HEC Pharm (0 Trials) |
|
| Heliocare (polypodium leucotomos extract) / Ferndale (0 Trials) |
|
| Helios ocular insert (bimatoprost sustained release insert) / AbbVie (0 Trials) |
|
| Helix Partner-02 / BioCardia (0 Trials) |
|
| Hemady (dexamethasone tablets) / Dexcel Pharma (26 Trials) |
|
| HemaMax (rHuIL-12) / Neumedicines (2 Trials) |
|
| Hemapo (epoetin alfa biosimilar) / PT Kalbe Farma, Alliance, CIMAB (0 Trials) |
|
| Hemaseel HMN (fibrin sealant) / Haemacure (0 Trials) |
|
| hematologic Tumor Accurin / Pfizer (0 Trials) |
|
| Hemay005 / Tianjin Hemay Pharma (5 Trials) |
|
| Hemay007 / Tianjin Hemay Pharma (2 Trials) |
|
| Hemay022 / Tianjin Hemay Pharmaceutical (3 Trials) |
|
| Hemay808 / Tianjin Hemay Pharma (1 Trials) |
|
| Hemlibra (emicizumab-kxwh) / Roche (24 Trials) |
|
| Hemo-8r (recombinant coagulation factor VIII) / Hemobras (0 Trials) |
|
| HEMO-CAR-T / Hemogenyx, University of Pennsylvania (0 Trials) |
|
| Hemodynamic modulator / Boehringer Ingelheim (0 Trials) |
|
| Hemofil-M (human plasma derived coagulation factor VIII) / Takeda (0 Trials) |
|
| hemophilia A cell therapy / Sernova (0 Trials) |
|
| hemophilia A lentiviral gene transfer therapy / Ospedale San Raffaele, Sanofi (0 Trials) |
|
| hemophilia A therapeutic / Recursion Pharma (0 Trials) |
|
| hemophilia A therapeutic / Lambdagen Therap (0 Trials) |
|
| hemophilia A therapeutic / Generation Bio (0 Trials) |
|
| hemophilia A therapeutic / Precision BioSci (0 Trials) |
|
| hemophilia A therapy / Immusoft (0 Trials) |
|
| hemophilia B lentiviral gene transfer therapy / Ospedale San Raffaele, Sanofi (0 Trials) |
|
| Hemophilia specific therapeutic antibody / Initium Therap (0 Trials) |
|
| hemophilia therapy / 3B Pharma, Takeda (0 Trials) |
|
| Hemoraas (plasma-derived human coagulation factor VIII) / Tonrol Biopharm (0 Trials) |
|
| HemoRel A (anti - hemophilic factor) / Reliance Life Sciences (0 Trials) |
|
| hemp extract (CDE-001) / Emerald Health Research (0 Trials) |
|
| henatinib / Shanghai Inst. of Materia Medica, Jiangsu Hengrui Medicine (0 Trials) |
|
| Henletor (torsemide) / Orchid (5 Trials) |
|
| Hensify (crystalline hafnium oxide) / Nanobiotix (11 Trials) |
|
| Hepabig (hepatitis b immunoglobulin (human)) / VHB Life Sci (0 Trials) |
|
| Hepacid (pegargiminase) / Polaris Pharma (8 Trials) |
|
| Hepadvax (hepatitis B vaccine) / Vaxine (1 Trials) |
|
| HepaGam B (hepatitis B immune globulin intravenous (human)) / Emergent Biosolutions (0 Trials) |
|
| hepalatide (L47) / Shanghai HEP Pharma (2 Trials) |
|
| heparin / Ockham Biotech (0 Trials) |
|
| heparin sodium injection / Generic mfg. (43 Trials) |
|
| heparin-derived oligosaccharide (OPK-0018) / OPKO Health (0 Trials) |
|
| HepaStem (heterologous human adult liver-derived mesenchymal stem cells) / Promethera Biosci (3 Trials) |
|
| hepatitis B adjuvanted vaccine (HBAI20) / CyTuVax (0 Trials) |
|
| Hepatitis B Immunoglobulin -P (human hepatitis B immunoglobulin) / CSL Behring (0 Trials) |
|
| hepatitis B virus ribonuclease H inhibitor / Casterbridge Pharma (0 Trials) |
|
| Hepatocellular Carcinoma therapeutic / Saronic Biotech (0 Trials) |
|
| Hepatocellular Carcinoma therapeutic / Stanford University, American Gene Technologies (0 Trials) |
|
| Hepatocellular Carcinoma therapeutic / Aria Pharma (0 Trials) |
|
| Hepaton (thiazolidine) / Sedico (0 Trials) |
|
| Hepatoren (ifetroban) / Cumberland (0 Trials) |
|
| Hepatothera (human anti-HBs immunoglobulin) / Meiji Seika (0 Trials) |
|
| Hepavac (IMA970A) / Immatics, CureVac (0 Trials) |
|
| Hepavir B (pradefovir) / Bausch Health (1 Trials) |
|
| Hepbarna (BB-HB-331) / Benitec (0 Trials) |
|
| HepBQuin (human hepatitis B immunoglobulin) / Sanquin (0 Trials) |
|
| Hepcludex (bulevirtide) / MYR GmbH (4 Trials) |
|
| hepenofovir / Xi’an XinTong Pharma (1 Trials) |
|
| Hepko-V5 (hepcortespenlisimut-L) / Immune Network (0 Trials) |
|
| Heplisav-B (hepatitis B vaccine (recombinant), adjuvanted) / Dynavax (6 Trials) |
|
| Hepta (epoetin alfa biosimilar) / Roemmers (0 Trials) |
|
| HepTcell (FP-02.2) / Altimmune (1 Trials) |
|
| HER-2/neu peptide vaccine / National Cancer Institute - Bethesda (5 Trials) |
|
| Her-VAXX / Pevion, Imugene (1 Trials) |
|
| HER1-VSSP vaccine / Center of Molecular Immunology (0 Trials) |
|
| HER2 Affibody / Bayer (2 Trials) |
|
| HER2 affitoxin / National Cancer Institute (0 Trials) |
|
| HER2 inhibitor / Cylene (0 Trials) |
|
| HER2 mAb / LFB SA (0 Trials) |
|
| HER2 Targeted Topoisomerase 1 CDC / Elucida Oncology (0 Trials) |
|
|